NEWSROOM Press Releases

Search Title:

Lung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy

July 10, 2017

Peer reviewed journal: VeriStrat test identifies patients with squamous cell lung cancer who are more likely to have improved survival on afatanib (Gilotrif)

Biodesix Announces VeriStrat® Data in Head and Neck Cancer to be Presented at ASCO

May 14, 2009

Christine Chung, MD, Assistant Professor of Medicine at Vanderbilt University will be presenting data on Veristrat at the 45th Annual Meeting of ASCO.

Our Tests

Our Biopharma Services

How We Help

Diagnostic Solutions

Our Purpose

For Providers

For Research

For Patients

Patients

Office Hours:

NEWSROOM Press Releases

Lung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy

Biodesix Announces VeriStrat® Data in Head and Neck Cancer to be Presented at ASCO